Skip to main content
. 2020 Aug 8;37(10):2413–2418. doi: 10.1007/s10815-020-01914-3

Table 1.

Patents’ laboratory/embryological data following the first embryo transfer

Fresh day-3 blastomere Bx FET day-3 blastomere Bx P value
Group A1 Group B1
No. of patients 236 132
Total no. of cycles 347 182
Mean age (years) 32.6 ± 4.8 32.3 ± 4.5 0.425
Indications for PGT-M
Single gene disorders 301 171
Chromosomal abnormalities 37 10
Sex selection 9 1
Mean OPU 9.9 ± 4.8 17.23 ± 8.9 < 0.001
Mean 2PN 7.2 ± 3.9 10.7 ± 5.9 < 0.001
Mean FR 0.74 ± 0.2 0.65 ± 0.2 < 0.001
Mean no of day-3 biopsied embryos 5.6 ± 3.3 5.9 ± 2.9 0.368
Total number of 2PN 2509 1940
Total number of embryos cryopreserved 1547
Total number of embryos thawed 1162
Embryos survived post-thawing (%) 1082/1162 (93.1)
Total number of embryos biopsied 1964 1078
Total number of embryos with complete diagnosis 1639 880
Embryos with complete diagnosis per embryo biopsied (%) 1639/1964 (83.5) 880/1078 (81.6) 0.208
No. of ETs 253 152
No. of embryos transferred 324 207
Ongoing PR (%) 75/253 (29.6) 40/152 (26.3) 0.467
Ongoing implantation rate (%) 84/324 (25.9) 46/207 (22.2) 0.327

FET frozen-thawed embryo transfer